Cardlytics CDLX announces its next round of earnings this Tuesday, May 04. Here is Benzinga's everything-that-matters guide for this Tuesday's Q1 earnings announcement.
What Are Earnings, Net Income, And Earnings Per Share?
Earnings and EPS are useful metrics of profitability. Total earnings also known as net income is equal to total revenue minus total expenses. Dividing net income by the total number of shares outstanding yields EPS.
Earnings And Revenue
Wall Street analysts see Cardlytics reporting a loss of $0.34 per share on revenue of $51.46 million. In the same quarter last year, Cardlytics reported EPS of $0.26 on revenue of $45.51 million.
Why Analyst Estimates And Earnings Surprises Are Important
Analysts who cover this company will publish forward-looking estimates of its revenue and EPS each quarter. Averaging together every EPS and revenue prediction that each analyst makes about a company in a quarter yields the "consensus estimates." A company posting earnings or revenue above or below the consensus estimate is known as an "earnings surprise" and may move the stock by a considerable margin.
The analyst consensus estimate would represent a 30.77% decline in the company's EPS figure. Revenue would be have grown 13.08% from the same quarter last year. Here is how the company's reported EPS has stacked up against analyst estimates in the past:
Quarter | Q4 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
---|---|---|---|---|
EPS Estimate | -0.03 | -0.28 | -0.47 | -0.21 |
EPS Actual | -0.05 | -0.16 | -0.38 | -0.26 |
Revenue Estimate | 60.89 M | 38.85 M | 30.84 M | 44.21 M |
Revenue Actual | 67.08 M | 46.08 M | 28.22 M | 45.51 M |
Stock Performance
Over the last 52-week period, shares of Cardlytics are up 191.64%.
Do not be surprised to see the stock move on comments made during its conference call. Cardlytics is scheduled to hold the call at 17:00:00 ET and can be accessed here.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.